We will trace all issued general and product specific guidance of medical device and IVD with analysis as of 2021. In additional to general and product specific standards in parallel, it helps you as legal manufacturers to prepare upcoming registration of medical device and IVD with full compliance.
The new issued guidance incorporates essential requirements of submission dossier. Oft are details of performance parameters, risk management, type testing, product technical requirement, clinical evaluation, clinical study, labelling, verification and validation specified. It is wise to fulfil these new additional requirements to avoid deficiency in the next product registration.
Unlike standards, guidance of medical device and IVD has no transition period. It means when draft is to published, legal manufacturers should be aware of new requirements. Once the guidance is issued, the new requirements have to be fulfilled in the upcoming and next registration.
Issued date: 2022-09-28
Issued date: 2022-09-15
Issued date: 2022-08-26
Issued date: 2022-06-28
Issued date: 27.06.2022
Issued date: 02.06.2022
Issued date: 26.05.2022
Issued date: 28.04.2022
Issued date: 01.04.2022
Issued date: 16.03.2022
Issued date: 03.03.2022
Issued date: 02.03.2022
Issued date: 28.02.2022
Issued date: 19.01.2022
Issued date: 17.01.2022
Issued date: 20.12.2021
issued date 27.09.2021
There are two guidances regarding animal test: I Decision-making principle; II Test design, implementation quality assurance. These guidelines are applicable to deciding whether medical devices need to be tested in vivo on live animals, excluding research conducted on non-living animals, isolated tissues or organs. In the first guidance the product code for potencial ainmal testing is given as example.
issued date 27.09.2021
Product code: 06-01-03 and 06-05-12
This guidance is applicable to the mammography machine with product code 06-01-03 and its attached product code 06-05-12 stereo positioning device for mammography. In annex there are valuable examples of
1. Product composition
2. Risk management
3. Product technical requirements template
4. Configuration table
5. Change product component inspection standards
6. Requirements for clinical evaluation through medical devices of the same variety
7. Clinical trial requirements
8. List of terms and abbreviations
issued date 27.09.2021
This guidance applies to vision screeners, not to refractors (including: desktop refractors and hand-held refractors)
issued date 08.05.2021
Product code: 02-06-01
The products applicable are disposable sterile closure clips (hereinafter referred to as closure clips) mainly used to clamp blood vessels or close tubular tissues in surgical operations, including small and medium arteries and veins, bile ducts, etc. It is not suitable for large arteries and large veins.
Issued date 08.05.2021
Product code: 17-05-01
It applies to dental glass ionomer cement products. Dental glass ionomer cements are also known as polyalkenate glass cements, glass ionomer cements, glass ionomer cements. They are generally powdery or pasty. They are reacted by fluoroaluminosilicate glass powder and polyalkenic acid aqueous solution, or Cement cured by reacting fluoroaluminosilicate glass powder/polyalkenic acid powder mixture with water or tartaric acid aqueous solution.
Issued date 08.05.2021
Product code: 14-01-06
Needle for injection pen refers to the injection needle product used with injection pen. It is provided aseptically and used for one time. It usually consists of outer sheath, inner sheath, needle tube, needle seat, and sealing dialysis paper (sealing film). The outer sheath and the sealing dialysis paper (sealing film) together constitute the initial packaging of the product. The needle tube is generally a double-ended needle, which is often used for subcutaneous injection of drugs.
Issued date 08.05.2021
Product code: 10-04-03
The disinfectant involved in this guidance, the main active ingredient is citric acid, and generally can also contain lactic acid and malic acid, which are used for heating and disinfecting the internal pipelines of the hemodialysis machine. This guidance does not apply to disinfectants that use peracetic acid, sodium hypochlorite, hydrogen peroxide, etc. as the main components to disinfect the internal pipelines of hemodialysis machines.
Issued date 15.04.2021
IVD.
Human parvovirus B19 IgM/IgG antibody detection reagent is based on the principle of antigen-antibody reaction, using immunochromatography, enzyme-linked immunoassay, chemiluminescence and other detection techniques to detect B19 IgM/IgG in human samples such as serum or plasma. Reagents for in vitro qualitative detection of IgG antibodies.
Issued date 15.04.2021
IVD.
It applies to real-time polymerase chain reaction to detect GBS nucleic acid. It is for in vitro qualitative testing of GBS from human samples such as vaginal swabs, rectal swabs, vaginal and rectal joint swabs from pregnant women or in vitro cultured human samples.
Issued date 15.04.2021
IVD.
Issued date 15.04.2021
IVD.
Issued date 15.04.2021
Prouct Code: 22-05-03
It applies to the above real-time fluorescent PCR instruments that perform qualitative or quantitative detection based on real-time fluorescent PCR detection technology, and is suitable for the amplification part of fully automatic equipment. It is not suitable for other nucleic acid analyzers with non-real-time fluorescent PCR amplification principles, nor for digital PCR machines. For non-applicable nucleic acid analyzers, please refer to the relevant applicable provisions of this guidance to prepare registration application materials.
Issued date 01.02.2021
It applies to clinical evaluation of common MR systems as well as MR components of multi-modal systems such as PET/MR systems. Intraoperative MR systems, special MR systems suitable for special parts such as breast/limbs, and special MR systems suitable for specific populations such as pediatrics can also be clinically evaluated according to the applicable requirements of this guidance. It does not apply to the clinical evaluation of MR systems with magnetic field strength greater than 3.0T, software parts with auxiliary decision-making functions, quantitative imaging and magnetic resonance spectroscopy imaging technologies
Issued date 19.01.2021
IVD.
It applies to the use of enzyme-linked immunosorbent assay, latex agglutination test and lateral immunochromatography based on the principle of antigen-antibody reaction, for the detection of human samples derived from serum and/or plasma and/or whole blood and/or cerebrospinal fluid. Reagent for in vitro qualitative detection of cryptococcal capsular polysaccharide antigen.
Issued date 19.01.2021
IVD.
It applies to the use of enzyme-linked immunosorbent assay, latex agglutination test and lateral immunochromatography based on the principle of antigen-antibody reaction, for the detection of human samples derived from serum and/or plasma and/or whole blood and/or cerebrospinal fluid. Reagent for in vitro qualitative detection of cryptococcal capsular polysaccharide antigen.
Issued date 19.01.2021
IVD.
It applies to reagents for the in vitro qualitative detection of Mycoplasma pneumoniae IgM and/or IgG antibodies in human serum, plasma or whole blood by immunochromatography, enzyme-linked immunoassay or chemiluminescence method.
Product code 06-07-xx
It applies clinical evaluation of Imaging Ultrasound Diagnostic Equipment.
The original guidance is all in Chinese. Write us an email to get the link and the English translation with corresponding cost if needed.
If you need all regulations matching your product code. Upon request we can provide you periodic regulatory update in service as below in customer need with precise gap analysis:
Dear Sir/Madam,
Thank you for contacting us.
We will answer you as soon as possible.
regards,
CEO
Antonio Lee
Easychinapprov
China, Germany
Frankfurt, Stuttgart Germany
Sun Dong An Plaza, No. 138
Beijing China
info@easychinapprov.com
0049-17638379004
Follow us in Linkedin and Youtube
E-Learning "MyComplinace"
Learning Chinese regulation and global regulatory affairs
Participation possible any time.
Discount during black week 19% ~ 50%
Article:
International market of medical device for Startups,SME
Overseas inspecion starts again
Testing beyond and for registration
Significant changes of medical device in China, EU, MDSAP countries
Meet us in next conference:
Arab health in Dubai, 2025 Jan
Global compliance and training
All Rights Reserve | Easychinapprov